🔎 Trials Near Me

Gara Jalqabaatti › Sarcoma Ewing › Distaarikii Koloombiyaa

Qorannoo klinikaalii Sarcoma Ewing Distaarikii Koloombiyaa keessatti

Qorannoo 6 Sarcoma Ewing f Distaarikii Koloombiyaa keessatti hirmaatuu jiru.

Magaalota Distaarikii Koloombiyaa keessatti

Takkalaa qorannoo (Ingiliffa)

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT04851119

Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)

  • Children's National Hospital, Washington D.C.
  • Childrens National Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 23 · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT07172958

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

  • Sibley Memorial Hospital, Washington D.C.
Namoota walitti qabaa jira
Hanga umuriin 39 · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT06796543

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT04901702

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Children's National Hospital, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 2 hanga 30 · Saalaa hunda · Haaromfame 03-Gur-2026 · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's National Medical Center, Washington D.C.
Namoota walitti qabaa jiraSadarkaa 2
18 Months – 40 Years · Saalaa hunda · Haaromfame 12-Hag-2025 · NCT05135975

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.